Canopy Growth Corporation - Common Shares (CGC)

The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.

Tilray shares rose ~5% after launching three EU-GMP medical cannabis strains in Germany and confirming renewed Nasdaq bid-price compliance.

Cannabis stocks and ETFs skyrocketed after Trump hinted at reclassifying marijuana. Tilray surged 35% in 2 days. Other top performers included Trulieve, Tilray, Curaleaf, and Canopy Growth. This shift could ease federal regulations and improve the industry's growth potential.

Tilray stock surged 14.13% after hours as reports of a possible marijuana reclassification by Trump fueled investor optimism.

Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that President Trump is considering reclassifying marijuana as a less dangerous drug.

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Canopy Growth reported higher-than-expected Q1 revenue fueled by cannabis sales, but margins narrowed and earnings missed analyst expectations.